COSCIENS Biopharma Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2015 | — | -6,400.7% | -9,200.6% |
| FY2016 | 100.0% | -3,235.6% | -2,739.7% |
| FY2017 | 100.0% | -2,499.9% | -1,819.7% |
| FY2018 | 92.2% | 36.6% | 15.6% |
| FY2019 | 22.9% | -1,925.2% | -1,135.7% |
| FY2020 | 36.6% | -156.2% | -140.1% |
| FY2021 | 98.3% | -164.8% | -159.1% |
| FY2022 | 58.7% | 29.6% | 23.7% |
| FY2023 | 41.1% | -64.8% | -48.8% |
| FY2024 | 49.3% | -190.7% | -159.7% |
| FY2025 | 35.3% | -142.5% | -138.1% |